Isolate name | Percent mortality (±SE) from a single-dose trial* | df | F | P | |||
---|---|---|---|---|---|---|---|
3 days | 5 days | 7 days | 9 days | ||||
BbKm-1 | 0.0±0.0aB** | 6.7±3.3cdB | 13.3±3.3bB | 36.7±8.8eA | 11 | 10.2 | 0.004 |
BbKm-2 | 0.0±0.0aC | 16.7±3.3abcdBC | 26.7±6.7abAB | 40.0±0.0deA | 11 | 20.5 | 0.000 |
BbDm-1 | 6.7±3.3aC | 33.3±3.3aB | 43.3±6.7abB | 93.3±3.3abA | 11 | 67.6 | 0.000 |
BbFn-3 | 0.0±0.0aC | 3.3±3.3dBC | 13.3±3.3bB | 46.7±3.3deA | 11 | 54.6 | 0.000 |
BbKp-1 | 3.3±3.3aB | 10.0±5.8bcdB | 23.3±8.8abAB | 53.3±8.8cdeA | 11 | 9.8 | 0.005 |
BbAk-1 | 0.0±0.0aC | 3.3±3.3dC | 26.7±3.3abB | 56.7±6.7cdeA | 11 | 41.1 | 0.000 |
BbSr-1 | 10.0±5.8aB | 13.3±8.8abcdB | 30.0±10.0abB | 76.7±6.7abcA | 11 | 14.8 | 0.001 |
BbKr-1 | 3.3±3.3aB | 10.0±5.8bcdB | 20.0±5.8abB | 80.0±0.0abcA | 11 | 63.4 | 0.000 |
BbDs-2 | 10.0±5.8aC | 26.7±3.3abcBC | 46.7±8.8aB | 96.7±3.3aA | 11 | 42.3 | 0.000 |
BbMg-1 | 3.3±3.3aB | 16.7±3.3abcdB | 20.0±0.0abAB | 36.7±6.7eA | 11 | 11.3 | 0.003 |
BbMg-2 | 16.7±3.3aB | 30.0±0.0abB | 36.7±8.8abB | 93.3±3.3abA | 11 | 45.7 | 0.000 |
BbMp-1 | 10.0±5.8aB | 26.7±3.3abcC | 50.0±0.0aB | 93.3±6.7abA | 11 | 58.8 | 0.000 |
BbGp-1 | 3.3±3.3aB | 10.0±5.8bcdB | 23.3±6.7abB | 66.7±8.8bcdA | 11 | 19.4 | 0.000 |
BbKl-1 | 0.0±0.0aC | 6.7±3.3cdC | 30.0±5.8abB | 80.0±0.0abcA | 11 | 118.3 | 0.000 |
df | 41 | 41 | 41 | 41 | |||
F | 2.2 | 5.1 | 3.3 | 15.7 | |||
P | 0.035 | 0.000 | 0.004 | 0.000 |